Linagliptin improves glycaemic control independently of diabetes duration and insulin resistance in patients with type 2 diabetes

被引：0
|
作者：
Patel, S. [1 ]
Weber, S. [2 ]
Emser, A. [2 ]
von Eynatten, M. [2 ]
Woerle, H. -J. [2 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[2] Boehringer Ingelheim KG, D-6507 Ingelheim, Germany
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
832
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [21] Dietary soy phytoestrogen intake reduces insulin resistance and improves glycaemic control in postmenopausal women with type 2 diabetes
    Jayagopal, V
    Albertazzi, P
    Kilpatrick, ES
    Howarth, E
    Jennings, PE
    Hepburn, DA
    Atkin, SL
    DIABETES, 2002, 51 : A139 - A139
  • [22] Insulin glargine improves glycaemic control in patients with type 2 diabetes on multiple daily insulin injections confirmed by using the CGMS
    Zick, R
    Richter, M
    Schiwietz, J
    Schweitzer, MA
    Petersen, B
    DIABETOLOGIA, 2005, 48 : A305 - A306
  • [23] Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naive Patients with Type 2 Diabetes
    Esteghamati, Alireza
    Nakhjavani, Manouchehr
    Aminorroaya, Ashraf
    Aboutorabi, Robabeh
    Niafar, Mitra
    Mohammadi, Mohammad
    Parvaresh, Ehsan
    JOURNAL OF DIABETES & METABOLISM, 2011, 2 (03)
  • [24] Erythromycin improves glycaemic control in patients with Type II diabetes mellitus
    Ueno, N
    Inui, A
    Asakawa, A
    Takao, F
    Tani, S
    Komatsu, Y
    Itoh, Z
    Kasuga, M
    DIABETOLOGIA, 2000, 43 (04) : 411 - 415
  • [25] LINAGLIPTIN IMPROVES GLYCEMIC CONTROL INDEPENDENT OF BODY MASS INDEX IN PATIENTS WITH TYPE 2 DIABETES
    Rendell, Marc
    Chrysant, Steven
    Trujillo, Angelina
    Emser, Angela
    von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans-Juergen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S214 - S215
  • [26] Erythromycin improves glycaemic control in patients with Type II diabetes mellitus
    N. Ueno
    A. Inui
    A. Asakawa
    F. Takao
    S. Tani
    Y. Komatsu
    Z. Itoh
    M. Kasuga
    Diabetologia, 2000, 43 : 411 - 415
  • [27] Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
    von Websky, Karoline
    Reichetzeder, Christoph
    Hocher, Berthold
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 681 - 694
  • [28] Switching to insulin degludec (IDeg) improves glycaemic control in patients with Type 2 diabetes in a real-world setting
    Feher, M.
    Tentolouris, N.
    Knudsen, S.
    Lapolla, A.
    Prager, R.
    Phan, T. M.
    Wolden, M. L.
    Schultes, B.
    DIABETIC MEDICINE, 2018, 35 : 203 - 203
  • [29] High altitude trekking preceded by training improves glycaemic control and insulin sensitivity in patients with type 2 diabetes mellitus
    de Mol, P.
    Fokkert, M. J.
    de Vries, S. T.
    de Koning, E. J. P.
    Dikkeschei, B. D.
    Gans, R. O. B.
    Tack, C. J.
    Bilo, H. J. G.
    DIABETOLOGIA, 2011, 54 : S249 - S249
  • [30] Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
    Kapoor, D.
    Goodwin, E.
    Channer, K. S.
    Jones, T. H.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (06) : 899 - 906
12345